surmount-1 tirzepatide obesity nejm 2022 weight loss percent for maintenance of bodyweight reduction in people with in the USA (SURMOUNT-MAINTAIN): a multicentre, double-blind, randomised, placebo-controlled trial Semaglutide vs. Tirzepatide: Which Weight

Taking the Next Step Getting semaglutide for weight loss without diabetes is absolutely possible and increasingly common

The greater risk is health consequences from using unregulated products

Additionally, GLP-1 RAs reduced the risks of genital infections and bone fractures in individuals with T2DM

A January 2025 cross-sectional study found that of 79 websites selling compounded medications, nearly half didnt report known adverse effects (including nausea, vomiting, abdominal pain, fainting, headache, migraine, dehydration, acute pancreatitis, and gallstones) and warnings for compounded GLP-1s

Injection for Weight Loss: Injectable (Wegovy/Ozempic) is, on average, better